GGrantIndex
← Leaderboards

Debra A Kendall

University Of Connecticut Storrs

$6,803,425
Attributed
$8,345,721
Total exposure
5
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $969.5K · FY200519
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19

Funding mix

By agency

NIH$8,345,721 · 5

By mechanism

R01$7,472,129 · 3
R21$873,592 · 2

Top collaborators

Most similar at University Of Connecticut Storrs

Same institution · by research overlap

Others in their field

Top investigators on “Molecular

Research focus

MolecularTherapeutic AgentsLigandsResponseLaboratoriesPropertyStagingG-Protein-Coupled ReceptorsBaseReceptorSignal TransductionPhosphorylationPathway InteractionsBiochemicalEscherichia ColiAlkaline PhosphataseAgonistProtein TransportBinding (Molecular Function)Eating DisordersAttenuatedCouplingMapsNeuraxis

Grant awards (27)

CB1 Allosteric Modulators: Molecular, Cellular and In Vivo Pharmacology$478,136
R01 · FY2019 · DA · contact PI
CB1 Allosteric Modulators: Molecular, Cellular and In Vivo Pharmacology$489,316
R01 · FY2018 · DA · contact PI
CB1 Allosteric Modulators: Molecular, Cellular and In Vivo Pharmacology$157,998
R01 · FY2018 · DA · contact PI
CB1 Allosteric Modulators: Molecular, Cellular and In Vivo Pharmacology$498,694
R01 · FY2017 · DA · contact PI
Beta-Arrestin Signaling from the Cannabinoid 2 and mu Opioid Receptors$232,200
R21 · FY2017 · DA · contact PI
CB1 Allosteric Modulators: Molecular, Cellular and In Vivo Pharmacology$533,900
R01 · FY2016 · DA · contact PI
Novel CB1 Inverse Agonists for Investigation of Constitutive Signaling Activities$228,442
R21 · FY2016 · DA · contact PI
Beta-Arrestin Signaling from the Cannabinoid 2 and mu Opioid Receptors$207,200
R21 · FY2016 · DA · contact PI
Novel CB1 Inverse Agonists for Investigation of Constitutive Signaling Activities$205,750
R21 · FY2015 · DA · contact PI
Redesign of Structural Regions of Alkaline Phosphatase$357,592
R01 · FY2011 · GM · contact PI
Determinants of the Cannabinoid Receptor Life Cycle$287,975
R01 · FY2011 · DA · contact PI
Redesign of Structural Regions of Alkaline Phosphatase$361,204
R01 · FY2010 · GM · contact PI
Determinants of the Cannabinoid Receptor Life Cycle$296,881
R01 · FY2010 · DA · contact PI
Redesign of Structural Regions of Alkaline Phosphatase$364,058
R01 · FY2009 · GM · contact PI
Determinants of the Cannabinoid Receptor Life Cycle$299,880
R01 · FY2009 · DA · contact PI
Redesign of Structural Regions of Alkaline Phosphatase$277,650
R01 · FY2009 · GM · contact PI
Redesign of Structural Regions of Alkaline Phosphatase$362,468
R01 · FY2008 · GM · contact PI
Determinants of the Cannabinoid Receptor Life Cycle$298,083
R01 · FY2008 · DA · contact PI
Determinants of the Cannabinoid Receptor Life Cycle$304,000
R01 · FY2007 · DA · contact PI
Redesign of Structural Regions of Alkaline Phosphatase$317,948
R01 · FY2006 · GM · contact PI
Redesign of Structural Regions of Alkaline Phosphatase$325,600
R01 · FY2005 · GM
Redesign of Structural Regions of Alkaline Phosphatase$325,417
R01 · FY2004 · GM
Redesign of Structural Regions of Alkaline Phosphatase$311,066
R01 · FY2003 · GM
REDESIGN OF STRUCTURAL REGIONS OF ALKALINE PHOSPHATASE$264,445
R01 · FY2002 · GM
REDESIGN OF STRUCTURAL REGIONS OF ALKALINE PHOSPHATASE$256,824
R01 · FY2001 · GM
Redesign Of Structural Regions Of Alkaline Phosphatase$53,570
R01 · FY2001 · GM
REDESIGN OF STRUCTURAL REGIONS OF ALKALINE PHOSPHATASE$249,424
R01 · FY2000 · GM